Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues

Citation
Hu. Shetty et al., Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues, NEUROCHEM R, 25(4), 2000, pp. 431-435
Citations number
30
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROCHEMICAL RESEARCH
ISSN journal
03643190 → ACNP
Volume
25
Issue
4
Year of publication
2000
Pages
431 - 435
Database
ISI
SICI code
0364-3190(200004)25:4<431:TMADSM>2.0.ZU;2-G
Abstract
myo-Inositol is elevated in the Down syndrome (DS; trisomy 21) brain and ma y play a role in mental retardation. In the present study, we examined brai n regions and peripheral tissues of Ts65Dn mouse, a recently characterized genetic model of DS, for abnormal myo-inositol accumulation. A GC/MS techni que was used to quantitate myo-inositol and other polyol species (ribitol, arabitol, xylitol, and 1,5-anhydrosorbitol) in tissues from the Ts65Dn mice and control diploid mice. myo-Inositol was found to be elevated in frontal cortex, hippocampus, and brain stem but not in cerebellum of the Ts65Dn mo use. Among peripheral organs examined, liver and skeletal muscle were found to excessively accumulate myo-inositol. In all tissues, concentrations of polyol internal controls were normal. The Ts65Dn mouse is useful to study t he possible effect of elevated myo-inositol on cellular processes.